PubMed=1654226; DOI=10.1093/carcin/12.9.1627
Park N.-H., Min B.-M., Li S.-L., Huang M.-Z., Cherick H.M., Doniger J.
Immortalization of normal human oral keratinocytes with type 16 human papillomavirus.
Carcinogenesis 12:1627-1631(1991)

PubMed=1330348; DOI=10.1093/carcin/13.11.1981
Li S.-L., Kim M.S., Cherrick H.M., Doniger J., Park N.-H.
Sequential combined tumorigenic effect of HPV-16 and chemical carcinogens.
Carcinogenesis 13:1981-1987(1992)

PubMed=10675494; DOI=10.3892/ijo.16.3.591
Itakura M., Mori S., Park N.-H., Bonavida B.
Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis.
Int. J. Oncol. 16:591-597(2000)

PubMed=12907203; DOI=10.1016/S1368-8375(03)00049-6
Swan E.A., Jasser S.A., Holsinger F.C., Doan D., Bucana C.D., Myers J.N.
Acquisition of anoikis resistance is a critical step in the progression of oral tongue cancer.
Oral Oncol. 39:648-655(2003)

PubMed=21868764; DOI=10.1158/1078-0432.CCR-11-0690; PMCID=PMC3229662
Zhao M., Sano D., Pickering C.R., Jasser S.A., Henderson Y.C., Clayman G.L., Sturgis E.M., Ow T.J., Lotan R., Carey T.E., Sacks P.G., Grandis J.R., Sidransky D., Heldin N.-E., Myers J.N.
Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites.
Clin. Cancer Res. 17:7248-7264(2011)

PubMed=32574978; DOI=10.1016/j.tranon.2020.100808; PMCID=PMC7317296
Nair T.S., Thomas T.B., Yang L., Kakaraparthi B.N., Morris A.C., Clark A.M., Campredon L.P., Brouwer A.F., Eisenberg M.C., Meza R., Carey T.E.
Characteristics of head and neck squamous cell carcinoma cell lines reflect human tumor biology independent of primary etiologies and HPV status.
Transl. Oncol. 13:100808.1-100808.9(2020)